Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

metlife inc. - MET

MET

Close Chg Chg %
69.88 0.52 0.74%

Closed Market

70.40

+0.52 (0.74%)

Volume: 2.51M

Last Updated:

Mar 25, 2026, 3:59 PM EDT

Trade Now

Company Overview: metlife inc. - MET

MET Key Data

Open

$71.00

 Day Range

69.50 - 71.18

52 Week Range

65.21 - 84.97

 Market Cap

$45.57B

Shares Outstanding

652.05M

 Public Float

546.14M

Beta

0.75

 Rev. Per Employee

N/A

P/E Ratio

14.83

 EPS

$4.74

Yield

324.80%

 Dividend

$0.57

EX-DIVIDEND DATE

Feb 3, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

4.35M

  

MET Performance

1 Week
 
 1.94%
 
1 Month
 
 -3.02%
 
3 Months
 
 -12.96%
 
1 Year
 
 -11.79%
 
5 Years
 
 14.91%
 

MET Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 21
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 91.733
Number of Ratings 21 Current Quarters Estimate 2.189
FY Report Date 03 / 2026 Current Year's Estimate 9.783
Last Quarter’s Earnings 2.49 Median PE on CY Estimate N/A
Year Ago Earnings 8.83 Next Fiscal Year Estimate 10.934
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 16 18 17
Mean Estimate 2.19 2.48 9.78 10.93
High Estimates 2.32 2.63 10.30 11.45
Low Estimate 2.11 2.26 9.61 10.55
Coefficient of Variance 2.77 3.48 1.78 2.14

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 10 10 11
OVERWEIGHT 3 3 2
HOLD 8 8 7
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Metlife Inc. - MET

Date Name Shares Transaction Value
Mar 13, 2026 William E. Kennard Director 45,780 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 3,232,068.00
Mar 13, 2026 Robert Glenn Hubbard Director 104,630 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 7,386,878.00
Mar 13, 2026 Christian Mumenthaler Director 2,125 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 150,025.00
Mar 13, 2026 Carla A. Harris Director 9,764 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 689,338.40
Mar 13, 2026 Diana L. McKenzie Director 23,751 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 1,676,820.60
Mar 13, 2026 Jeh Charles Johnson Director 8,129 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 573,907.40
Mar 13, 2026 Laura J. Hay Director 4,971 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $70.6 per share 350,952.60
Apr 4, 2025 Denise M. Morrison Director 32,255 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Cheryl W. Grisé Director 88,189 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 7,157,419.24
Apr 4, 2025 Carlos Miguel Gutierrez Director 23,289 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Edward Joseph Kelly Director 36,849 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 2,990,664.84
Apr 4, 2025 David Lawrence Herzog Director 26,138 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share 2,121,360.08
Apr 4, 2025 Mark Alan Weinberger Director 16,345 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Metlife Inc. in the News